GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSUY) » Definitions » Cyclically Adjusted FCF per Share

Embla Medical hf (Embla Medical hf) Cyclically Adjusted FCF per Share : $0.12 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Embla Medical hf Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Embla Medical hf's adjusted free cash flow per share for the three months ended in Mar. 2024 was $-0.017. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.12 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Embla Medical hf's average Cyclically Adjusted FCF Growth Rate was 2.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 8.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Embla Medical hf was 10.40% per year. The lowest was 5.50% per year. And the median was 8.70% per year.

As of today (2024-05-01), Embla Medical hf's current stock price is $4.50. Embla Medical hf's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.12. Embla Medical hf's Cyclically Adjusted Price-to-FCF of today is 37.50.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Embla Medical hf was 77.36. The lowest was 25.49. And the median was 46.25.


Embla Medical hf Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Embla Medical hf's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Cyclically Adjusted FCF per Share Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.02 0.14 0.10 0.15

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.14 0.17 0.15 0.12

Competitive Comparison of Embla Medical hf's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Embla Medical hf's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cyclically Adjusted Price-to-FCF falls into.



Embla Medical hf Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Embla Medical hf's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.017/142.1253*142.1253
=-0.017

Current CPI (Mar. 2024) = 142.1253.

Embla Medical hf Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.037 98.777 0.053
201409 0.057 98.734 0.082
201412 0.044 98.669 0.063
201503 -0.005 99.612 -0.007
201506 0.027 100.289 0.038
201509 0.031 100.607 0.044
201512 0.042 100.657 0.059
201603 0.012 101.115 0.017
201606 0.008 101.923 0.011
201609 0.037 102.457 0.051
201612 0.037 102.562 0.051
201703 0.005 102.768 0.007
201706 0.031 103.496 0.043
201709 0.034 103.871 0.047
201712 0.057 104.481 0.078
201803 -0.011 105.600 -0.015
201806 0.022 106.206 0.029
201809 0.042 106.727 0.056
201812 0.036 108.388 0.047
201903 0.010 108.702 0.013
201906 0.042 109.758 0.054
201909 0.086 109.922 0.111
201912 0.015 110.588 0.019
202003 0.039 111.019 0.050
202006 0.046 112.667 0.058
202009 0.053 113.772 0.066
202012 0.026 114.542 0.032
202103 0.023 115.833 0.028
202106 0.051 117.451 0.062
202109 0.031 118.723 0.037
202112 0.066 120.398 0.078
202203 0.011 123.555 0.013
202206 0.004 127.809 0.004
202209 0.028 129.810 0.031
202212 0.037 131.901 0.040
202303 -0.005 135.674 -0.005
202306 0.025 139.150 0.026
202309 0.041 140.147 0.042
202312 0.061 142.125 0.061
202403 -0.017 142.125 -0.017

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Embla Medical hf  (OTCPK:OSSUY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Embla Medical hf's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4.50/0.12
=37.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Embla Medical hf was 77.36. The lowest was 25.49. And the median was 46.25.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Embla Medical hf Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (Embla Medical hf) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.